Financial Perspectives Inc bought a new position in Elevance Health, Inc. (NYSE:ELV – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 135 shares of the company’s stock, valued at approximately $50,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ELV. Raelipskie Partnership bought a new stake in shares of Elevance Health in the third quarter worth about $26,000. PSI Advisors LLC purchased a new position in shares of Elevance Health during the third quarter valued at approximately $27,000. Eastern Bank bought a new position in shares of Elevance Health during the third quarter valued at approximately $31,000. Crews Bank & Trust purchased a new stake in Elevance Health in the fourth quarter worth $34,000. Finally, Dunhill Financial LLC boosted its holdings in Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after acquiring an additional 26 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors.
Elevance Health Stock Up 2.5 %
Shares of Elevance Health stock opened at $391.86 on Thursday. The company has a 50-day simple moving average of $384.93 and a two-hundred day simple moving average of $445.67. Elevance Health, Inc. has a 52-week low of $362.21 and a 52-week high of $567.26. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. The stock has a market capitalization of $90.88 billion, a PE ratio of 15.30, a price-to-earnings-growth ratio of 1.17 and a beta of 0.83.
Elevance Health Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a $1.71 dividend. This represents a $6.84 annualized dividend and a yield of 1.75%. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is presently 25.46%.
Wall Street Analysts Forecast Growth
ELV has been the subject of several research analyst reports. Barclays raised their target price on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company cut their price objective on Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Mizuho decreased their target price on Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded Elevance Health from a “hold” rating to a “buy” rating in a research note on Tuesday, February 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $485.00 price target on shares of Elevance Health in a research note on Friday, January 24th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $517.03.
Get Our Latest Analysis on Elevance Health
Elevance Health Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Recommended Stories
- Five stocks we like better than Elevance Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the Hang Seng index?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Industrial Products Stocks Investing
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.